Filter results by document type and/or working area to find what you're searching for.
Once the analysis results have been technically validated and considered reliable, they can be looked at from a clinical angle to search for suspect results. The task of biomedical validation is to recognise abnormal or conspicuous quantita¬tive results. Based on the findings compiled by the GFHC, there is a new rule set implemented in Extended IPU looking at things such as cut-off values, assessment of previous values or additional patient information. Check out the recommendation from GFHC.
Unser Poster zeigt die Hämatopoese aus blutzellbildenden Stammzellen nach Ceredig R et al. Nat Rev Immunol 2009, 9(4): 293–300. Die Darstellung der Hämatopoese als Modell des „Sonnensystems“ basiert auf der Idee der hohen Flexibilität und der engen Beziehung zwischen den verschiedenen Arten von Vorläuferzellen. Viele Vorläufer haben gemeinsame Transkriptionsfaktoren. Anstelle einer klassischen Baumdarstellung der Hämatopoese schlagen Ceredig R et al. diese Darstellung vor, um die invarianten paarweisen Entwicklungsbeziehungen zwischen den verschiedenen hämatopoetischen Linien zu zeigen.
What you always wanted to know about haemophilia can be found in this SEED. Starting with what haemophilia actually is, this article outlines the cause, effects and late effects, as well as former and current treatment methods. The reader will also receive guidance on the laboratory diagnosis of haemophilia A and B, as well as on the detection of anti-factor VIII antibodies.
Urinary tract infections (UTI) belong to the most common bacterial infections and, though suspected cases often turn out to be negative, contribute to high laboratory workloads and empiric prescription of antibiotics, a main driver antimicrobial resistance (AMR). This white paper reviews the strengths of the UF-series in ruling-out UTI, supporting its diagnosis and potential applications to further optimise the UTI laboratory workflow, aiming to fight AMR.
Diagnostics play a major role in the rational prescription of antibiotics. Well-known antimicrobial susceptibility tests (AST) are reliable tools for the phenotypic determination of resistance to antibiotics . Several solutions to support AST performance are available on the market.
This clinical information card focuses on the clinical use of IPF# (immature platelet fraction abolsute count) for coronary artery disease patients. The parameter helps monitoring the efficacy of antiplatelet drug therapy and assessing the risk of future cardiovascular thrombotic events.